Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Argenx
Argenx
Go or no go? Argenx's December showdown
EP Vantage
Wed, 12/1/21 - 10:10 am
FDA
Argenx
efgartigimod
myasthenia gravis
Calliditas
Nefcon
Merck
Keytruda
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
Fierce Pharma
Mon, 09/13/21 - 11:38 pm
FDA
Pfizer
Argenx
UCB Pharma
Roche
efgartigimod
bimekizumab
faricimab
abrocitinib
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
FDA
drug approvals
Argenx
Novartis
AstraZeneca
Astellas
UCB Pharma
Ascendis Pharma
ChemoCentryx
Axsome Therapeutics
Johnson & Johnson culls $1.6B argenx blood cancer drug collab
Fierce Biotech
Mon, 06/7/21 - 11:02 am
JNJ
biobucks
Belgium
Argenx
cusatuzumab
AgomAb raises $74M to develop regenerative pathway modulators
Fierce Biotech
Wed, 03/10/21 - 10:34 am
AgomAb
regenerative pathway modulators
Argenx
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
Biopharma Companies Entering 2021 With New Collabs, Partnerships
BioSpace
Sat, 01/9/21 - 07:42 pm
M&A
Argenx
Zai Lab
Dewpoint Therapeutics
Pfizer
CureVac
Bayer
Sanofi
Nurix Therapeutics
3 Biotech Stocks That Could Explode Higher in 2021
Motley Fool
Mon, 12/21/20 - 10:58 am
biotech
biotech stocks
clinical trials
FDA
Argenx
Axsome Therapeutics
CRISPR Therapeutics
Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
Fierce Biotech
Mon, 11/23/20 - 10:16 am
Argenx
Bayer
FDA
priority reviews
efgartigimod
ITP
10 most valuable R&D projects in the pharmaceutical industry pipeline
Beckers Hospital Review
Mon, 07/20/20 - 11:49 pm
R&D
drug development
Eli Lilly
Novartis
Argenx
Bristol-Myers Squibb
Vir Biotechnolgy
Biogen
GSK
Iovance
Roche
Biotech Argenx's autoimmune phase 3 hits goals, teeing up FDA filing
Fierce Biotech
Tue, 05/26/20 - 11:07 am
Argenx
efgartigimod
myasthenia gravis
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Fri, 11/15/19 - 11:14 am
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease
Argenx and Halozyme Ink Multiple Target Deal That Could Hit $540 Million
BioSpace
Mon, 02/4/19 - 11:33 am
Argenx
Halozyme Therapeutics
drug delivery
drug development
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
Tue, 12/4/18 - 11:27 am
GSK
Tesaro
M&A
Big Pharma
JNJ
Argenx
ASH18: Argenx pens $1.6B biobucks Janssen pact for blood cancer hopeful cusatuzumab
Fierce Biotech
Mon, 12/3/18 - 09:55 am
Argenx
Cilag
Janssen
cusatuzumab
ASH2018
blood cancers
Argenx To Raise $300 million in U.S. public offering
CP Wire
Wed, 09/19/18 - 11:44 am
Argenx
AbbVie doubles down on cancer project with biotech group Argenx
Yahoo/Reuters
Wed, 08/22/18 - 09:49 am
Argenx
AbbVie
ARGX-115
cancer immunotherapy
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
CP Wire
Thu, 06/28/18 - 10:10 am
Argenx
AbbVie
ARGX-115
cancer
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug
Thu, 06/28/18 - 10:08 am
Argenx
Argenx IPO haul tops out at $115M, 50% above initial goal
Fierce Biotech
Tue, 05/23/17 - 08:06 am
Argenx
IPOs
Pages
« first
‹ previous
1
2
3
next ›
last »